Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Raven McCloud who wrote (443)	3/16/1999 9:21:00 PM
From: QuietWon	Respond to of 2515

I agree on trading it and have a smaller core position. Biotech news takes longer to develop than other techs (eg computer/communication/internet)

To: Raven McCloud who wrote (443)	3/16/1999 9:26:00 PM
From: rick barrows	Respond to of 2515

To: Quiet Won From:mrmcc1 According to Jim McCamant there will be a presentation on the renal cell carcinoma trial at this years ASCO meeting in May. I have been waiting to hear about this trial for some time. The trial involved 53 patients and the results are supposed to be very encouraging.I would think that since this form of cancer is so difficult to treat that good results should help expedite approval.

To: Raven McCloud who wrote (443)	3/16/1999 9:40:00 PM
From: Douglas Freeman	Respond to of 2515

I side with the bulls. I had Imclone on my list of heavy insider buying to look into, & when the news broke on CNBC I was immediately curious. Then I see; 13 of 15 people had tumors eliminated, the other 2 shrank 50%. You just don't see numbers like that (I haven't in the last few days anyway, anyone else?). Unless the results are a lie of some fashion, I'd label that bullish. Among other things, the pullback only lasted a day before buyers moved in. That cinched it for me. Some people have mentioned we have a news "gap"; I'm counting on that gap. All sorts of time for people to look into IMCL & accumulate, and you probably have 3 times the people who know it exists now (analysts, portfolio managers, & myself included), AND we get to rest on this nice bullish tone for a while. A couple more points & I'll take the standard chunk off the table, but I agree with the nice gradual uptrend theory, say into the low 20's in 6 months. It's when they actually have to post some results (or anything else that changes the tone) that you run into some risk. Very few stocks go straight up to a certain point, then flatline, making the word "accumulate" a well-used term on Wall St. There's another heavy duty bullish situation brewing, which I'll mention in a couple days as soon as I'm done buying it. It was what I bought 2 weeks ago instead of Imclone. Has a nice, dead thread too. ID